“The right target, at the right time, for the right price”  …is and always has been a guiding principle for Merck KGaA, as stated by its...

The first-line metastatic Melanoma market is currently dominated by immune checkpoint inhibitors—BMS' Opdivo + Yervoy, Opdualag, Opdivo,...